KOREA LIFE SCIENCE WEEK
HOME SEMINAR & CONFERENCE > CONFERENCE

Bio-ventures & Startups Investment Forum | IPIR

Promising Bio Venture·Startup Investment Forum

Date Time Venue Conference Organizer File Regist
Nov 13(Wed) 10:00-15:30
 Seminar B in exhibition hall B2

2024 THE 2ND PROMISING BIO VENTURE - STARTUP INVESTMENT FORUM

 Korea Drug Research Association
10:00-10:30

Registration
10:30-10:40

Opening Greeting/KDRA Pharmaceutical and Bio Business Development Research Council
10:40-12:00

Session 1 : President, Yuntaek Jung (Pharmaceutical Development organization)
10:40-11:00

Treatment for Geriatric Diseases (Senile Sarcopenia, Alzheimer's Dementia)
 ALIAD BIOPHARM
11:00-11:20

Senile Sarcopenia Treatment
 Mitos Therapeutics Inc.
11:20-11:40

RNA Therapeutics (Therapeutic mRNA loaded on target-oriented LCLN)
 Uniwon Pharm Gene Inc.
11:40-12:00

Next-generation Treatments for wAMD and DR on the Ang-Tie Axis
 NeortesBio
12:00-13:30

LUNCH
13:30-15:00

Session 2 : Vice President, Wontae Jung (Korea United Pharm)
13:30-13:50

Single-cell Multi-omics based Precision Medicine Platform for Disease-specific Diagnosis a
 einocle
13:50-14:10

Antibody Conjugated NanoParticles Platform
 KMD Bio
14:10-14:30

AI Virtual Human System and Multi-omics-based Proprietary Platform 'SyMthomics' for the Development of Global Innovative Multi-component, Multi-target Drugs

 MTHERA PHARMA
14:30-14:50

Generative AI and Quantum Mechanics-powered Drug Design Platform with Quantum Computing Technologies
 inCerebro
14:50-15:10

POC Brain Cooling System for Acute Brain Injury Protection Based on Lowpressure Vortex Tube Technology
ASTRON
15:10-15:15

Closing

IPIR 2024

Date Time Venue Conference Organizer File Regist
Nov 14(Thu) 10:00-15:30
 Seminar B in exhibition hall B2

IR FROM RESEARCH AND DEVELOPMENT-ORIENTED SUPERIOR
PHARMACEUTICAL AND BIO COMPANY

 Korea Drug Research Association
 [Closed]
apply
10:00-10:30

Registration

 [Closed]
apply
10:30-10:40

Opening Greeting : Korea Drug Research Association,
General Manager, Hunjae Cho
 [Closed]
apply
10:40-12:00

Session 1 : Executive Director, Gwangyoung Jang (OneCureGEN)

 [Closed]
apply
10:40-11:00

Development of New Drugs of First-in-Class and Best-in-Class, Targeting Autoimmune and Inflammatory Diseases
 S&K Therapeutics
 [Closed]
apply
11:00-11:20

Development of Innovative Anti-Cancer Immune Cell Therapy Using
Natural Killer Cells (NK Cells)
 UCI Therapeutics
 [Closed]
apply
11:20-11:40

NK Cell-based Cell Therapy Drug Development and Process
Technology Platform Service
 Onco Insight
 [Closed]
apply
11:40-12:00

Development of Microorganism-based Functional Materials
 Bae Ryeo Innovation
 [Closed]
apply
12:00-13:30

Lunch

 [Closed]
apply
13:30-15:30

Session 2 : President, Sunshyun Hong (Clichem BIO)

 [Closed]
apply
13:30-13:50

Anticancer Nano Drug Delivery Technology
 SN BioScience
 [Closed]
apply
13:50~14:10

Development of Five Anticancer Drug Pipelines, Including Anticancer
Radiosensitizers
 VS PharmTech
 [Closed]
apply
14:10-14:30

Development of Candidate Substances used for Incurable Cancer such as Glioblastoma, Head and Neck Cancer, Triple-Negative Breast Cancer, and Non-small Cell Lung Cancer
 Astrion
 [Closed]
apply
14:30-14:50

Development of Improved New Drugs and Vaccines Based on
Microneedle Technology
 JUVIC
 [Closed]
apply
14:50-15:10

Development of Innovative Hair Loss Treatments in Various
Modalities
 Epibiotech
 [Closed]
apply
15:10-15:30

Total Aptamer Solution from Early Diagnosis of Disease to Treatment
 Aptamer Sciences Inc.
 [Closed]
apply
15:30

Closing

 [Closed]
apply